United States Influenza Vaccines market: USD 3.5 Opportunity

United States Influenza Vaccines market is set to touch US$ 3.5 Billion threshold by 2025.   “United States Influenza Vaccines Market Report, Analysis and Forecast to 2025” presents an in-depth assessment of the United States influenza vaccines market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the most up-to-date industry data […]

United States Vaccines Market 2015 – 2025: Top 21 Vaccines Analysis, Deal Trends, Players and Forecasts

United States vaccines market is set to surpass US$ 21 Billion threshold by 2025. “United States Vaccines Market 2015 – 2025: Top 21 Vaccines Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the United States vaccines market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the most up-to-date […]

United States Influenza Vaccine Market Witness Huge Growth by 2025 | Leading Key Players: Sanofi, GlaxoSmithKline (GSK), Seqirus, AstraZeneca

United States Influenza Vaccines market is set to touch US$ 3.5 Billion threshold by 2025.   “United States Influenza Vaccines Market Report, Analysis and Forecast to 2025” presents an in-depth assessment of the United States influenza vaccines market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the most up-to-date industry data […]

United States Pediatric Vacccine Market Size by Top Key Players Like Sanofi Pasteur, GlaxoSmithKline(GSK), Merck & Co., Pfizer Inc and Grifols 2018 – 2025

United States pediatric vaccines market is expected to grow over US$ 15 Billion by 2025, driven by increased disease awareness, growing public acceptance, increasing government focus on immunization programs and increased government funding for the vaccines development. “Pediatric Vaccines Market: United States Industry Analysis, Trends, Opportunity, Market Size and Segment Forecasts, 2018 – 2025” provides a […]

US Pediatric Vaccines Market Estimated To Reach $15 Billion By 2025

United States pediatric vaccines market is expected to grow over US$ 15 Billion by 2025, driven by increased disease awareness, growing public acceptance, increasing government focus on immunization programs and increased government funding for the vaccines development. “Pediatric Vaccines Market: United States Industry Analysis, Trends, Opportunity, Market Size and Segment Forecasts, 2018 – 2025” provides a […]

Supplemental Biologics License Application for .5 mL Influenza Vaccine in Children 6-35 Months Accepted by FDA

Source: http://www.contagionlive.com/ The US Food and Drug Administration (FDA) accepted for review a supplemental Biologics License Application seeking to expand the age indication of the 0.5 mL dose of Sanofi Pasteur’s influenza vaccine (Fluzone Quadrivalent) to include children between 6 and 35 months of age. The target action date is January 28, 2019, per the Prescription […]

Pediatric Associates and TruMed Systems, Maker of the AccuVax Vaccine Management System, Join Forces to Improve Delivery of Vaccines to Florida Infants and Children

Source: http://www.citizentribune.com/ In conjunction with World Immunization Week and National Infant Immunization Week, Pediatric Associates of Florida and TruMed Systems, maker of the AccuVax Vaccine Management System, jointly announced that AccuVax will be used at all Pediatric Associates sites to optimize vaccine storage and management. Pediatric Associates, America’s largest private pediatric practice, is replacing its conventional […]

GSK to Compensate for Merck’s Pediatric HepB Vaccine Shortage

Source: https://www.aafp.org/ Merck & Co. Inc. has announced that because of a continuing manufacturing issue, its shortage of pediatric hepatitis B (HepB) recombinant vaccine (Recombivax HB) will continue through the rest of 2018. On its Current Vaccine Shortages & Delays webpage,(www.cdc.gov) the CDC said GlaxoSmithKline will mitigate the shortage of pediatric HepB vaccines with supply to meet full […]